Senator Representing Oyo South Senatorial District, Kola Balogun

Tracereporters –Senator Representing Oyo South Senatorial District, Kola Balogun has identified synergy among all tiers of governments, practitioners and private partners to sustain quality health delivery to Nigerians.


He called on all stakeholders in the health sector to redouble their efforts, saying the present challenges posed serious threat to the infrastructural investments in health sector.


Speaking at the official launching of Actigraft, the first wound care product that enables health care providers to produce – in real time – in vitro blood clots from a patient’s blood to the site of the chronic wound to initiate and support the body’s natural healing process in Abuja on Wednesday, Sen. Balogun said the government is poised at addressing the shortage in man power and issue of fragment among practitioners.


Sen. Balogun called on both the Federal, State and Local Government to continue to be by the side of the people, adding that quality health care remain utmost in government priorities.


“Federal government is doing its best, the States and local governments must not relent in prioritising infrastructure investment in the health sector. We should not also look away from the public, private partnerships which I believe will go a long way to address our present challenges.” Sen. Balogun urged.


In his address, the Chief Medical Officer, Lone Star Global Consult Ltd, Dr. David Obasi Ukoha pointed out reason for partnering Grant In International, from Israel and IES Medical NG Ltd to add Actigraft into Nigeria medical advancement, citing that the innovation will significantly reduce the lead time, risk, cost, and resources required in efficacious therapies in the healing process of chronic and hard to heal wounds.


According to him, “It has been a great challenge for health care providers treating patients with chronic wounds that fail to heal, or heal slowly, there has been an underlying factors that impedes local blood flow to the wound site and hinders the body’s natural wound healing processes.


“These types of wounds may never heal, or take years to heal, causing patients severe emotional and physical stress and creating a significant financial burden on patients and the whole healthcare system and in addition could eventually lead to wound infection, necrosis & finally – limps amputation. Patients suffering from chronic wounds, experience severe damage to their health and wellness with severe pain, low self esteem and severe impairment of quality of life. With ACTIGRAFT on our shelves, lasting solution is here”.


During his presentation, the Managing Director, IES Medical NG Limited, Mr. Eitan Kariv, opined that it required a concerted effort to develop new faster healing agents, especially as an effective compound for hard to heal wounds, adding that Nigeria now have all it takes to stop medical tourism in this regards and get treated even right at the comfort of their homes.


He said with Actigraft the duration of treatment reduces and in days or weeks, chronic wounds and hard to heal wounds will disappear comfortably with lesser pains.

Leave a Reply